Torrent Pharmaceuticals

Torrent's 2025-26 integrated report says the company is evaluating the deployment of end-to-end e-workflow systems for BA and BE studies, and advanced AI tools for literature screening. Only the literature-screening tools are described as AI.

A strategy scorecard in Torrent's 2024-25 integrated report lists implementing AI tools for quality management systems.

Torrent's 2024-25 integrated report says the company is evaluating AI tools to optimise various regulatory and quality-related activities, with the stated aim of faster decision-making and improved compliance management.

In its account of operations at Dahej, Torrent's 2023-24 integrated report says that, with an eye on the future, the company is integrating AI, ML and IoT to drive higher automation, optimisation and decision making, setting the stage for Pharma 5.0.